Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors

Early Human Development

Volumn 88, Issue 12, 2012, Pages 937-941

  Mintz Hittner, Helen A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

"" pegaptanib, ranibizumab, bevacizumab, aflibercept ; Intravitreal injections; Near confluent laser therapy; Retinopathy of prematurity (ROP); Vascular endothelial growth factor inhibitors (anti VEGF)

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; GATIFLOXACIN; MOXIFLOXACIN; PEGAPTANIB; RANIBIZUMAB; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ANTISEPSIS; ARTICLE; BLINDNESS; CATARACT; CLINICAL TRIAL (TOPIC); CRYOTHERAPY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EPIDEMIC; EVIDENCE BASED MEDICINE; HUMAN; LENS LUXATION; LOW LEVEL LASER THERAPY; PATHOGENESIS; PREMATURITY; PRENATAL DEVELOPMENT; RECURRENT DISEASE; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINA DEVELOPMENT; RETINA TEAR; RETROLENTAL FIBROPLASIA; SCREENING; THERAPY RESISTANCE; TREATMENT OUTCOME; VITRECTOMY;

ANTIBODIES, MONOCLONAL, HUMANIZED; APTAMERS, NUCLEOTIDE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RETINOPATHY OF PREMATURITY; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84868665052     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2012.09.019     Document Type: Article

References (15)

1. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008, 84:77-82.
2. The Committee for the Classification of Retinopathy of Prematurity The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005, 123(11):991-999.
3. Capone A., Ells A.R., Fielder A.R., et al. Standard image of plus disease in retinopathy of prematurity. Arch Ophthalmol 2006, 124(11):1669-1670.
4. Section of Ophthalmology AAoP, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology, Strabismus Screening examination of premature infants for retinopathy of prematurity (policy statement). Pediatrics 2006, 117(2):572-576.
5. Section of Ophthalmology AAoP, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology, Strabismus Errata: screening examination of premature infants for retinopathy of prematurity (policy statement). Pediatrics 2006, 118(3):1324.
6. Early Treatment for Retinopathy of Prematurity Cooperative Group Revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol 2003, 121(12):1684-1694.
7. Cryotherapy for Retinopathy of Prematurity Cooperative Group Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988, 106(4):471-479.
8. Chen J., Smith L. Retinopathy of prematurity. Angiogenesis 2007, 10(2):133-140.
9. Mintz-Hittner H.A., Kretzer F.L. Postnatal retinal vascularization in former preterm infants with retinopathy of prematurity. Ophthalmology 1994, 101(3):548-558.
10. Mintz-Hittner H.A., Knight-Nanan D.M., Satriano D.R., Kretzer F.L. A small avascular zone may be an historic mark of prematurity. Ophthalmology 1999, 106(7):1409-1413.
11. Kong L., Mintz-Hittner H.A., Penland R.L., Kretzer F.L., Chevez-Barrios P. Intravitreal bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study. Arch Ophthalmol 2008, 126(8):1161-1163.
12. Hoang Q.V., Kiernan D.F., Chua F.Y., Shapiro M.J., Blair M.P. Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol 2010, 128(8):1080-1081.
13. Mintz-Hittner H.A., Kennedy K.A., Chuang A.Z. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity: preliminary results of the BEAT-ROP clinical trial. N Engl J Med 2011, 364(7):603-627. BEAT-ROP Cooperative Group.
14. Wu W.-C., Yeh P.-T., Chen S.-N., Yang C.-M., Lai C.-C., Kuo H.-K. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. Ophthalmology 2011, 118(1):176-183.
15. Autrata R., Krejcirova I., Senkova K., Holousova M., Dolezel Z., Borek I. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II. Eur J Ophthalmol 2012, 22(5):687-694.